Table 5 Association between the laboratory tests and predictor variables in 159 oral carcinoma patients.
CRP | alb | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
< 3 | 3≤ | ≤ 38 | 38< | |||||||
n (of 96) | % | n (of 63) | % | p value | n (of 83) | % | n (of 76) | % | p Value | |
Periodontal stability | ||||||||||
present | 52 | 67.5 | 25 | 32.5 | 41 | 53.2 | 36 | 46.8 | ||
not present | 44 | 53.7 | 38 | 46.3 | 0.078 | 42 | 51.2 | 40 | 48.8 | 0.874 |
Marginal bone loss | ||||||||||
not present | 15 | 65.2 | 8 | 34.8 | 12 | 52.2 | 11 | 47.8 | ||
mild | 38 | 65.5 | 20 | 34.5 | 23 | 39.7 | 35 | 60.3 | ||
moderate | 32 | 56.1 | 25 | 43.9 | 34 | 59.6 | 23 | 40.4 | ||
Severe | 10 | 50.0 | 10 | 50.0 | 0.547 | 14 | 70.0 | 6 | 30.0 | 0.060 |
Total number of teeth | ||||||||||
0 | 9 | 56.3 | 7 | 43.8 | 10 | 62.5 | 6 | 37.5 | ||
1–12 | 9 | 56.3 | 7 | 43.8 | 8 | 50.0 | 8 | 50.0 | ||
13–24 | 36 | 56.3 | 28 | 43.8 | 39 | 60.9 | 25 | 39.1 | ||
25–32 | 42 | 66.7 | 21 | 33.3 | 0.620 | 26 | 41.3 | 37 | 58.7 | 0.129 |
Stage | ||||||||||
I–II | 54 | 65.1 | 29 | 34.9 | 42 | 50.6 | 41 | 49.4 | ||
III–IV | 42 | 55.3 | 34 | 44.7 | 0.256 | 41 | 53.9 | 35 | 46.1 | 0.751 |
T-class | ||||||||||
Tis–T2 | 67 | 67.0 | 33 | 33.0 | 49 | 49.0 | 51 | 51.0 | ||
T3–T4 | 29 | 49.2 | 30 | 50.8 | 0.030 | 34 | 57.6 | 25 | 42.4 | 0.327 |
Lymph node status | ||||||||||
N0 | 73 | 62.9 | 43 | 37.1 | 61 | 52.6 | 55 | 47.4 | ||
N1 or more | 22 | 51.2 | 21 | 48.8 | 1.000 | |||||
Site | ||||||||||
Tongue | 45 | 64.3 | 25 | 35.7 | 38 | 54.3 | 32 | 45.7 | ||
Gum or palate | 30 | 55.6 | 24 | 44.4 | 34 | 63.0 | 20 | 37.0 | ||
Floor of the mouth | 15 | 60.0 | 10 | 40.0 | 7 | 28.0 | 18 | 72.0 | ||
Cheek | 6 | 60.0 | 4 | 40.0 | 0.793 | 4 | 40.0 | 6 | 60.0 | 0.027 |